Surgeon-Designed Foot & Ankle Technologies

Toetal Solutions creates innovative technologies that are transforming outcomes.

A Toetal Hammertoe Solution

The Toetal Solutions’ ZipToe™ Hammertoe System features a cutting-edge design built for the ASC that enables foot and ankle surgeons to address rigid hammertoe deformities with seamless precision.
01

SEAMLESS PRECISION, TOETAL STABILITY

ZipToe™ incorporates a user-friendly design that meets the core tenants of proper bone fusion — offering seamless precision and stability.
02

SIMPLE-TO-IMPLANT DESIGN

ZipToe™ has been thoughtfully designed with surgeon input from inception to production to ensure the best clinical outcomes possible by providing active compression and eliminating rotation.
03

UNIQUELY BUILT FOR THE ASC

ZipToe™ features a proprietary deployable nitinol implant that comes sterile-packed with all necessary disposable instrumentation to perform the procedure in any surgical setting.

Meet Our Leadership Team

Toetal Solutions is made up of a dedicated group of surgeons and industry veterans that bring innovative and differentiated clinical solutions to providers. Toetal Solutions is executive management is provided by Runway Management Corp.

Management Team

Jeff O’Donnell, Jr

Co-Founder, President & CEO

Bill Rhoda

Co-Founder, Chief Technology Officer

Kaileen Osisek

Project Manager

Surgeon-Led Design Team

Dr. Nicholas M. Romansky

Dr. Nicholas M. Romansky, DPM

Dr. Stephen Soondar

Dr. Stephen Soondar, DPM

Board of Directors

Jeffrey F. O’Donnell, Sr.

Executive Chairman

William John Odenthal

Director
Nick Pachuda

Nick Pachuda

Director

Bill Rhoda

Co-Founder, Chief Technology Officer

Jeff O’Donnell, Jr

Co-Founder, President & CEO

News

Toetal Solutions Raises $1.02 Million in New Financing

Yahoo! Finance

Toetal Solutions Secures $1,800,000 in New Financing to Pursue Product Development and Regulatory Approval

Newswire
CONTACT US

Ready for a transformation?

Let's Talk
Contact Us
To learn more about what Toetal Solutions can do for you, tell us about yourself and we’ll get back to you soon.
© 2024 toetal. All Rights Reserved
Close

Jeff O’Donnell, Jr

Co-Founder, President & CEO

Jeff O’Donnell, Jr is a healthcare entrepreneur who has merged a foundational corporate beginning with start-up agility. Jeff began his career and development at large Fortune 500 organizations. Throughout his tenure, Jeff has held almost every role in commercial organizations from Product Management to VP of Sales and Marketing. Since 2013, Jeff has helped grow and operate multiple emerging growth start-ups in the Orthopedic, Cardiology, and Digital Health spaces. He is a proud graduate of the Haub School of Business at Saint Joseph’s University, in Philadelphia.

Currently, Jeff is the President of Runway Management Corp., which oversees the direct management of the Runway Healthcare, LP portfolio companies. Jeff serves as CEO of Waypoint Orthopedics, Inc., and of Toetal Solutions, Inc.

Additionally, Jeff is a Managing Partner of MAST Labs, LLC. and sits on the boards of various healthcare companies.

Close

Bill Rhoda

Co-Founder, Chief Technology Officer

Bill Rhoda has a long history in the orthopedics implant space, starting his career with Synthes Spine in the late ’90s as a product development engineer. Bill later became a founding member of Globus Medical, serving as the Vice President of Product Development. He has developed a rapid product development process that dramatically shortened the time from concept to market introduction from 2+ years to 12 months. Since his time at Globus in 2012, Bill has helped form and develop new and innovative companies as well as helped create a MedTech venture capital firm with multiple exits. Bill is a graduate of Drexel University and serves as the Chair for the Dean‘s Executive Advisory Council for Drexel’s Biomedical Engineering school. Bill also serves on the boards of various medical device companies.

Close

Kaileen Osisek

Project Manager
Close
Dr. Nicholas M. Romansky

Dr. Nicholas M. Romansky, DPM

As a Board-Certified Diplomate of the American Board of Podiatric Surgery, Dr. Romansky earned his undergraduate bachelor’s degree at Hartwick College in New York and a graduate degree in Exercise Physiology/Cardiac Rehabilitation at The Pennsylvania State University. His podiatric medicine degree was accomplished at Pennsylvania College of Podiatric Medicine followed with a one year residency at Riverside Hospital in Ohio and an additional year of residency at Hayward Hospital in California. Dr. Romansky completed his training with a year long Foot and Ankle Orthopedic Fellowship in the San Francisco area.

Dr. Romansky is a contributing editor to Podiatry Today magazine and lectures nationwide for various organizations. He is a team podiatrist for the U.S. Men’s and Women’s National and World Cup  Soccer Teams, a design consultant to multiple shoe gear companies and a medical consultant to many of Philadelphia’s professional sports teams. Most recently, Dr. Romansky has been working as a health consultant for the Major League Baseball Umpires Association (MLBUA).

In his free time, Dr. Romansky enjoys watching sports, landscaping, running, and cross-training. He also likes traveling, meeting new people, and trying foreign food.

Close
Dr. Stephen Soondar

Dr. Stephen Soondar, DPM

Dr. Soondar is a member of the American Podiatric Medical Association and a Fellow of the American College of Foot and Ankle Surgeons. He is Board Certified in Foot Surgery, Reconstructive Rearfoot and Ankle Surgery. He graduated from Temple University’s School of Podiatric Medicine and has been published in the Journal of Foot and Ankle Surgery. Dr. Soondar specializes in Lower Extremity Trauma, Charcot Foot Reconstruction, Limb Salvage, and Ankle Arthroscopy as well as the comprehensive scope of Forefoot and Rearfoot medicine. He is a member of the Visitor’s and Founder’s boards at Temple University’s School of Podiatric Medicine and is the Assistant Director of Phoenixville Hospital’s Podiatry Residency Program.

In his free time, you can find Dr. Soondar watching all of the Philadelphia sports teams or spending time with his wife and young son. Dr. Soondar appreciates a diverse exercise and has recently been doing the Orange Theory workout in between his work and family life. Dr. Soondar will always take you up on a conversation about cars. He enjoys seeing new movies and finding new restaurants.

Close

Jeffrey F. O’Donnell, Sr.

Executive Chairman

Jeffrey O’Donnell, Sr. brings more than 25 years of Board and Chief Executive experience running emerging medical device firms. Businesses under his direct leadership have achieved over $1.5 Billion in value creation from initial public offering of stock or mergers and acquisitions.

Jeff retired as CEO and Founder of Trice Medical an emerging growth medical device company developing in-office arthroscopy tools. In 2008, Jeff founded and ran Embrella Cardiovascular, a medical device startup company, which was sold in 2011 to Edwards Life sciences (NYSE: EW). Prior to Embrella Cardiovascular, Jeff served as President and CEO of PhotoMedex (NASDAQ: PHMD) from 1999 to 2009. Prior to PhotoMedex, Jeff was the President and CEO of Cardiovascular Dynamics. His team took CCVD public on NASDAQ in June of 1996 and purchased Radiance Medical Systems and Endologix (NASDAQ: ELGX). From 1994 to 1995 Jeff held the position of President and CEO of Kensey Nash Corporation (NASDAQ: KNSY). Additionally, he has held several senior sales and marketing management positions at Boston Scientific Corporation, Guidant Corporation and with Johnson & Johnson’s Orthopedic Division.

In 2005, Jeff was named Life Sciences CEO of the Year by Price Waterhouse Coopers, and in 2011 was named the Greater Philadelphia Emerging Entrepreneur of The Year by Ernst & Young.

Jeff is currently a Venture Partner of Laidlaw Venture Partners, the Chairman of the board of AerWave, a Director of Algorithm Sciences, and a Director of Accure Acne. He joined the AdvaMed Accel Board of Directors in 2016 and serves as an observer on the Membership, Ethics and Technology and Regulatory committees of the AdvaMed Board. Previously, Jeff served as Chairman of the Board for Strata Skin Sciences (NASDAQ: SSKN) (2 years), as well as a Director on the Board at Cardiac Science (7 yrs.) and Endologix (12 yrs.). Jeff is a graduate of LaSalle University and was recently inducted into the Beta Gamma Sigma, an international honors society.

Jeff serves as Executive Chairman to all Runway Healthcare, LP portfolio companies.

Close

William John Odenthal

Director

William Odenthal has over 37 years of capital markets and equities banking experience. In addition to his role as General Partner at Runway Healthcare, he currently is Principal and Head of Investment Banking for Alere Financial Partners, LLC., exploring innovative, small-capitalization public corporations, primarily in the biomedical sector; providing comprehensive banking and advisory initiatives.

In June of 2013, William founded Alere Financial Partners, LLC., as a division of Summer Street Research Partners. During his tenure at Summer Street, he served as Director of Investment Banking, managing all aspects of equities banking deals for Alere Financial Partners, LLC. Over his eighteen-month tenure at Summer Street, William oversaw and was the lead investment banker on over 40mm dollars of unregistered security placements to institutional investors.

Prior to Summer Street Research Partners, William instituted the advisory business at The Benchmark Company. As a leader of Capital Markets at Benchmark from March of 2007 until June 2013, he orchestrated dozens of non-deal roadshows and attended multiple investment conferences.

Additionally, William served as a Principal and Chief Operating Officer of Weatherly Securities for over five years supervising over 160 employees in three branch offices. Over his tenure at Weatherly, he was the President and Chief Operating Officer and acted as a principal of the firm.

Principal/Supervisory Exams

General Securities Principal Examination – Series 24
General Securities Representative Examination – Series 7
Uniform Securities Agent State Law Examination – Series 63
Investment Banking Representative Qualification Examination – Series 79

Close
Nick Pachuda

Nick Pachuda

Director
Close

Bill Rhoda

Co-Founder, Chief Technology Officer

Bill Rhoda has a long history in the orthopedics implant space, starting his career with Synthes Spine in the late ’90s as a product development engineer. Bill later became a founding member of Globus Medical, serving as the Vice President of Product Development. He has developed a rapid product development process that dramatically shortened the time from concept to market introduction from 2+ years to 12 months. Since his time at Globus in 2012, Bill has helped form and develop new and innovative companies as well as helped create a MedTech venture capital firm with multiple exits. Bill is a graduate of Drexel University and serves as the Chair for the Dean‘s Executive Advisory Council for Drexel’s Biomedical Engineering school. Bill also serves on the boards of various medical device companies.

Close

Jeff O’Donnell, Jr

Co-Founder, President & CEO

Jeff O’Donnell, Jr is a healthcare entrepreneur who has merged a foundational corporate beginning with start-up agility. Jeff began his career and development at large Fortune 500 organizations. Throughout his tenure, Jeff has held almost every role in commercial organizations from Product Management to VP of Sales and Marketing. Since 2013, Jeff has helped grow and operate multiple emerging growth start-ups in the Orthopedic, Cardiology, and Digital Health spaces. He is a proud graduate of the Haub School of Business at Saint Joseph’s University, in Philadelphia.

Currently, Jeff is the President of Runway Management Corp., which oversees the direct management of the Runway Healthcare, LP portfolio companies. Jeff serves as CEO of Waypoint Orthopedics, Inc., and of Toetal Solutions, Inc.

Additionally, Jeff is a Managing Partner of MAST Labs, LLC. and sits on the boards of various healthcare companies.